News
Codevax names Stephen D. Chubb to Board of Directors
June 22, 2011 - Codevax, Inc. a U.S. vaccine development company focused on preventing hospital acquired infections including MRSA and Acinetobactor baumannii is expanding. Stephen D. Chubb has been appointed to the Codevax Board of Directors.
Researchers Unzip MRSA and Discover Route for Vaccine
January 15-18, 2011 - URMC Team Presents Latest Data at National Orthopaedics Meeting.
URMC Newsroom: Researchers unzip MRSA and discover route for vaccine
As reported by Ivanhoe news service
Medical reporting from the Bone Research Society meeting
Evaluation of Anti-Glucosaminidase Monoclonal Antibodies as a Passive Immunization for Methicillin-Resistant Staphylococcus aureus (MRSA) Osteomyelitis
January 15-18, 2011 - Varrone, J.J., Daiss, J.L. & Schwarz, E.M. 2011. Evaluation of
Anti-Glucosaminidase Monoclonal Antibodies as a Passive Immunization for
Methicillin-Resistant. 88 KB Poster session presented at the 57th annual meeting
of the Orthopaedic Research Society, Long Beach, CA.
Events
Codevax CEO Attending 2011 BIO International Convention in Washington D.C.
Codevax's CEO, Mark Hankins will be attending the 2011 BIO meeting. Please contact Mr. Hankins if you would like to connect with him at the meeting.